99 related articles for article (PubMed ID: 36460239)
1. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
Sivakumar P; Nagashanmugam KB; Priyatharshni S; Lavanya R; Prabhu N; Ponnusamy S
Neurochem Int; 2023 Jan; 162():105461. PubMed ID: 36460239
[TBL] [Abstract][Full Text] [Related]
2. α-synuclein regulates Cyclin D1 to promote abnormal initiation of the cell cycle and induce apoptosis in dopamine neurons.
Jia X; Chen Q; Yao C; Asakawa T; Zhang Y
Biomed Pharmacother; 2024 Apr; 173():116444. PubMed ID: 38503238
[TBL] [Abstract][Full Text] [Related]
3. Rapid FRET Assay for the Early Detection of Alpha-Synuclein Aggregation in Parkinson's Disease.
Yu H; Feng R; Chen F; Wu Z; Li D; Qiu X
ACS Chem Neurosci; 2024 Apr; 15(7):1378-1387. PubMed ID: 38506367
[TBL] [Abstract][Full Text] [Related]
4. Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.
Nagatsu T; Nakashima A; Watanabe H; Ito S; Wakamatsu K
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456994
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation.
Ortiz de Ora L; Balsamo JM; Uyeda KS; Bess EN
ACS Chem Biol; 2024 Apr; 19(4):1011-1021. PubMed ID: 38517270
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the role of 3-nitrotyrosine residues in the formation of alpha-synuclein oligomers and fibrils.
Chavarría C; Ivagnes R; Zeida A; Piñeyro MD; Souza JM
Arch Biochem Biophys; 2024 Feb; 752():109858. PubMed ID: 38104957
[TBL] [Abstract][Full Text] [Related]
7. Levels of α- and β-synuclein regulate cellular susceptibility to toxicity from α-synuclein oligomers.
Angelova DM; Jones HBL; Brown DR
FASEB J; 2018 Feb; 32(2):995-1006. PubMed ID: 29054856
[TBL] [Abstract][Full Text] [Related]
8. Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers.
Wu S; Hernandez Villegas NC; Sirkis DW; Thomas-Wright I; Wade-Martins R; Schekman R
Elife; 2023 Jan; 12():. PubMed ID: 36626307
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules.
Natalello A; Brocca S; Ponzini E; Santambrogio C; Grandori R
Front Biosci (Landmark Ed); 2023 Oct; 28(10):266. PubMed ID: 37919088
[TBL] [Abstract][Full Text] [Related]
10. Single-Molecule Detection of α-Synuclein Oligomers in Parkinson's Disease Patients Using Nanopores.
Liu Y; Wang X; Campolo G; Teng X; Ying L; Edel JB; Ivanov AP
ACS Nano; 2023 Nov; 17(22):22999-23009. PubMed ID: 37947369
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human HspB5-ACD structural domain inhibits neurotoxicity by regulating pathological α-Syn aggregation.
Liu C; Ding X; Guo X; Zhao M; Zhang X; Li Z; Zhao R; Cao Y; Xing J
Int J Biol Macromol; 2024 Jan; 255():128311. PubMed ID: 37992927
[TBL] [Abstract][Full Text] [Related]
12. Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's disease.
Martinez PA; Martinez VE; Rani S; Murrell M; Javors M; Gelfond J; Doorn JA; Fernandez E; Strong R
Brain Behav; 2023 Sep; 13(9):e3150. PubMed ID: 37452461
[TBL] [Abstract][Full Text] [Related]
13. Conformational dynamics of α-synuclein and study of its intramolecular forces in the presence of selected compounds.
Khatooni Z; Akhtari K; Wilson HL
Sci Rep; 2023 Nov; 13(1):19020. PubMed ID: 37923923
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Synuclein Oligomers Driven T1-T2 Switchable Nanoprobes for Early and Accurate Diagnosis of Parkinson's Disease.
Chen Y; Liang Z; Wang Q; Xiao L; Xie S; Yang S; Liu X; Ling D; Li F
Adv Mater; 2024 Mar; 36(13):e2310404. PubMed ID: 38149464
[TBL] [Abstract][Full Text] [Related]
15. Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers.
Yoo G; Yeou S; Son JB; Shin YK; Lee NK
Sci Rep; 2021 May; 11(1):10955. PubMed ID: 34040104
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole.
Zhao YD; Zhang W; Xing LZ; Xu J; Shi WM; Zhang YX
Bioorg Med Chem Lett; 2024 Jun; 105():129752. PubMed ID: 38631541
[TBL] [Abstract][Full Text] [Related]
17. Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein.
Werner-Allen JW; Monti S; DuMond JF; Levine RL; Bax A
Biochemistry; 2018 Mar; 57(9):1462-1474. PubMed ID: 29394048
[TBL] [Abstract][Full Text] [Related]
18. Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of α-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress.
Cui Z; Guo FY; Li L; Lu F; Jin CH; Wang X; Liu F
Eur J Med Chem; 2024 Jan; 264():115965. PubMed ID: 38056304
[TBL] [Abstract][Full Text] [Related]
19. Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α-syn and Clearing ROS in Parkinson's Disease.
He M; Zhang X; Ran X; Zhang Y; Nie X; Xiao B; Lei L; Zhai S; Zhu J; Zhang J; Li R; Liu Z; Zhu Y; Dai Z; He Z; Feng J; Zhang C
Adv Mater; 2024 May; ():e2404576. PubMed ID: 38696266
[TBL] [Abstract][Full Text] [Related]
20. Alpha-Synuclein Aggregation Mechanism in the Presence of Nanomaterials.
Malik SA; Mondal S; Atreya HS
Biochemistry; 2024 May; 63(9):1162-1169. PubMed ID: 38668883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
